Partnerships in Clinical Trials in Mexico

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Partnerships in Clinical Trials in Mexico

Partnerships in Clinical Trials in Mexico – CRO Partner

Clinical trials play a pivotal role in advancing medical research, leading to the development of innovative treatments and medicines that benefit patients worldwide. In recent years, Mexico has emerged as a significant player in the field of clinical trials, attracting attention from pharmaceutical companies and research organizations alike.

The growing interest in conducting clinical trials in Mexico can be attributed to several factors, including its diverse patient population, supportive regulatory environment, and the increasing presence of experienced research institutions.

In this blog, we will explore the importance of partnerships in clinical trials in Mexico, shedding light on the collaborative efforts that have propelled medical research forward in the country.

The Rising Importance of Clinical Trials in Mexico

As the second-most populous country in Latin America, Mexico boasts a diverse demographic landscape that presents a unique opportunity for clinical research. A broad representation of patients across different ethnicities and medical conditions makes Mexico an attractive location for conducting trials.

This diversity not only aids in understanding how treatments may affect different populations but also enhances the generalizability of research findings.

Favorable Regulatory Environment

Mexico’s regulatory environment has evolved over the years, becoming more supportive of clinical trials. The Federal Commission for Protection against Sanitary Risk (COFEPRIS) oversees the approval process for clinical trials, ensuring adherence to international standards while also striving to expedite the approval process.

Additionally, the government has implemented measures to streamline administrative procedures, reducing the time and effort required to initiate and conduct trials in the country.

Infrastructure and Research Capabilities

The success of clinical trials hinges on the availability of well-equipped research centers and experienced investigators. Mexico boasts a growing number of specialized research institutions, both in the public and private sectors.

These institutions are often affiliated with major universities and hospitals, providing access to state-of-the-art facilities and a wealth of medical expertise. Collaborations between these institutions and pharmaceutical companies or contract research organizations (CROs) play a crucial role in facilitating the seamless execution of clinical trials.

Partnerships in Clinical Trials in Mexico

Partnerships in Clinical Trials in Mexico

Partnerships in Clinical Trials in Mexico

Patient Recruitment and Engagement

Recruiting a sufficient number of eligible patients is a critical challenge in clinical trials. Partnerships with local healthcare providers and patient advocacy groups help streamline the recruitment process by tapping into existing patient networks. Moreover, these partnerships foster trust and confidence in the clinical trial process among potential participants, leading to higher retention rates and improved data quality.

Accelerating Drug Development

The strategic location of Mexico between North and South America has made it an ideal hub for multi-country clinical trials. By partnering with Mexico, pharmaceutical companies can expand their research scope across borders, enabling simultaneous testing of investigational drugs in diverse populations. This approach accelerates drug development timelines and increases the chances of identifying drug responses that may vary among different ethnic groups.

Addressing Global Health Concerns

Mexico’s involvement in clinical trials extends beyond drug development. The country actively participates in research related to global health concerns, such as infectious diseases, vaccine development, and non-communicable diseases prevalent in the region. Partnerships between international organizations and Mexican research institutions have resulted in groundbreaking discoveries that contribute to global health knowledge.

Ethical Considerations and Patient Safety

Partnerships in clinical trials also emphasize ethical considerations and patient safety. Collaborators work closely to ensure that research protocols comply with internationally recognized ethical standards, safeguarding the well-being of trial participants. This commitment to ethical research enhances the credibility of clinical trials conducted in Mexico and fosters a positive reputation among the global research community.


In conclusion, partnerships in clinical trials have become instrumental in driving medical research forward in Mexico. With a diverse patient population, a supportive regulatory environment, and a growing network of research institutions, Mexico has emerged as a vital player in the global clinical trials landscape.

Collaborative efforts between pharmaceutical companies, research organizations, healthcare providers, and patient advocacy groups have facilitated the successful execution of trials, leading to advancements in medical science and improved healthcare outcomes for patients worldwide. As Mexico continues to foster a culture of collaboration and innovation, it will undoubtedly play an increasingly significant role in shaping the future of clinical research.

Partnerships in Clinical Trials in Mexico

Source: Roche

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Partnerships in Clinical Trials in Mexico

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Partnerships in Clinical Trials in Mexico

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Partnerships in Clinical Trials in Mexico

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Partnerships in Clinical Trials in Mexico

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Partnerships in Clinical Trials in Mexico

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Partnerships in Clinical Trials in Mexico

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Partnerships in Clinical Trials in Mexico

The Cohortias Team

Partnerships in Clinical Trials in Mexico

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Partnerships in Clinical Trials in Mexico

Network & Partnerships